CIMEX
Price
$26.05
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
131.88B
HRLYX
Price
$9.13
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Net Assets
60.67M
Interact to see
Advertisement

CIMEX vs HRLYX

Header iconCIMEX vs HRLYX Comparison
Open Charts CIMEX vs HRLYXBanner chart's image
American Funds Income Fund of Amer 529E
Price$26.05
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets131.88B
Hartford Real Asset Y
Price$9.13
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets60.67M
CIMEX vs HRLYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIMEX vs. HRLYX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMEX is a Buy and HRLYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMEX has more cash in the bank: 132B vs. HRLYX (60.7M). HRLYX (3.65) and CIMEX (3.52) have matching dividends . CIMEX was incepted earlier than HRLYX: CIMEX (23 years) vs HRLYX (15 years). HRLYX (1.25) is less costly to investors than CIMEX (0.84). HRLYX is a more actively managed with annual turnover of: 198.00 vs. CIMEX (92.00). CIMEX has a lower initial minimum investment than HRLYX: CIMEX (250) vs HRLYX (250000). CIMEX annual gain was more profitable for investors over the last year : 12.12 vs. HRLYX (6.85). HRLYX return over 5 years is better than : 50.93 vs. CIMEX (40.35).
CIMEXHRLYXCIMEX / HRLYX
Total Expense Ratio0.840.9192%
Annual Report Gross Expense Ratio0.841.2567%
Fund Existence23 years15 years-
Gain YTD8.07611.07173%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets132B60.7M217,463%
Annual Yield % from dividends3.523.6596%
Returns for 1 year12.126.85177%
Returns for 3 years17.3111.91145%
Returns for 5 years40.3550.9379%
Returns for 10 years63.8243.15148%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKDA4.790.17
+3.68%
Arcadia Biosciences
MRBK13.190.29
+2.25%
Meridian Corp
RGLS8.100.15
+1.89%
Regulus Therapeutics
BCRX10.97-0.07
-0.63%
BioCryst Pharmaceuticals
CVNA343.30-2.34
-0.68%
Carvana Co